Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards Insightful $186K to Develop Cancer Prevention Research Software

NEW YORK, Feb. 7 (GenomeWeb News) - The National Cancer Institute has awarded Insightful two contracts worth a total of $185,807 to develop advanced bioinformatics software to analyze and evaluate proteomic cellular signatures in cancer prevention research, Insightful said today.

 

The software will use Insightful's S-Plus 7 and S+ArrayAnalyzer products, the company said.

 

The initial contracts call for solutions to the "challenges of preprocessing mass spectrometry data," Insightful said. The company is planning to develop software that includes calibration, denoising, baseline detrending, intensity normalization, peak detection, alignment, feature selection and extraction, as well as graphics.

 

Insightful said the funding will be recorded in the company's financial statements as a reduction to research and development expense.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.